StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Constant Currency Growth in Rest of World (% cc) by Year

Constant Currency Growth in Rest of World (% cc) (%)

Novartis Constant Currency Growth in Rest of World (% cc): -6.0% in FY2025, down 1.0 pts from a year earlier. That is the lowest of the 8 years on record here.

Latest, FY2025
-6.0%
Period ended Dec 31, 2025
Change on a year earlier
-1.0 pts
-5.0% in FY2024
History
8 years
Since FY2018
Sources
8
Documents cited below

Where the FY2025 figure comes from

“|| Rest of portfolio | 2 177 | 1 | 7 842 | -6 | -6 | 10 019 | -5 | -4”

Source: Novartis Form 6-K (0001114448-26-000007) ↗

Reported in Form 6-K & Form 20-F.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedConstant Currency Growth in Rest of World (% cc) (%)Year on yearSource
FY2025Dec 31, 2025-6.0%-1.0 ptsNovartis Form 6-K (0001114448-26-000007) ↗
FY2024Dec 31, 2024-5.0%-10.0 ptsNovartis Form 6-K (0001370368-25-000007) ↗
FY2023Dec 31, 20235.0%+5.0 ptsNovartis Form 6-K (0001370368-24-000007) ↗
FY2022Dec 31, 20220.0%0.0 ptsNovartis Form 6-K (0001370368-23-000008) ↗
FY2021Dec 31, 20210.0%+5.0 ptsNovartis Form 6-K (0001370368-22-000009) ↗
FY2020Dec 31, 2020-5.0%-9.0 ptsNovartis Form 6-K (0001370368-21-000008) ↗
FY2019Dec 31, 20194.0%+4.0 ptsNovartis Form 6-K (0001370368-20-000007) ↗
FY2018Dec 31, 20180.0%–Novartis Form 6-K (0001370368-19-000006) ↗

Cite this data

StockData. (2026). Novartis Constant Currency Growth in Rest of World (% cc) (%), annual FY2018–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/portfolio-rest-row-yoy-cc-pct

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.